Education:
Jun’2003-Jul’2004: Post-doctoral fellow, Univ. of California, Irvine, USA. Mentor: Professor Larry E. Overman Worked in the area of design and synthesis of bio-active Natural product
July 2001-May 2003: Post-doctoral fellow, Univ. of Montreal, Montreal, Canada Mentor: Professor Stephen Hanessian Worked in the area of medicinal chemistry comprising structure-based pharmaceutical drug design and synthesis (aminoglycoside antibiotics).
Mar’2000-June 2001: Honorary research associate in the Department of Organic Chemistry, Indian Association for the Cultivation of Science, Jadavpur. Mentor: Professor Subrata Ghosh Studies on the synthesis of Mispyric Acid, a novel triterpene with potential utility against DNA β
Nov’2000: Received Doctoral degree from National Chemical Laboratory Pune-411008, India. Supervisor: Dr. Mukund K. Gurjar Thesis Title: “Syntheses of Some Novel Anti-asthmatic Agents and Lipooligosaccharide of Mycobacterium gordonae Strain 990”
Jul’1994-May 1995:Junior Research Fellow-GATE, India Institute of Technology, Kharagpur, India Mentor: Prof. Dipakranjan Mal Pursued research in the area of angucyclines. Refs: Tetrahedron, 1997, 53, 2177. Completed graduate level courses on Rheology of polymer, Principles of polymer systems and German Language-each are for four credits.
Jun’1994: Received M.Sc. (Master of Science) Degree in Chemistry (Organic Chemistry Major). Graduated with First Class from Indian Institute of Technology (IIT), Kharagpur-721302, India.
May 1992: Received B.Sc. (Honors) Degree in Chemistry from Ramkrishna Mission Vivekananda Centenary College, Rahara, 24-NPGs, under Calcutta University, India.
Award and Fellowships:
Awarded Graduate Aptitude Test in Engineering (GATE-94) Fellowship in IIT Kharagpur. Qualified SLET-94 conducted by W.B. College Service Commission
Awarded Doctoral Research Fellowship from Council of Scientific and Industrial Research (CSIR), Govt. of India
Meritorious certificate from Cytomed, Inc., USA (Millennium pharmaceuticals, Inc., at present) for development of CMI-977 bulk drugs
Present Research Interest:
a. Design and Development of Target Based New Chemical Entities for Breast-Prostate-ovarian Cancer and Malaria, Leishmania; Structure-based pharmaceutical drug design and synthesis.
b. Development of novel synthetic procedures for various potentially bioactive heterocyclic compounds from readily available starting materials.
c. Design and Development of fluorescent probes with nitrogen, oxygen and/or sulfur donor sites.
Publications and Patents :